429 related articles for article (PubMed ID: 19597142)
21. Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.
Alexandrov PN; Percy ME; Lukiw WJ
Cell Mol Neurobiol; 2018 Apr; 38(3):769-774. PubMed ID: 28687876
[TBL] [Abstract][Full Text] [Related]
22. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
[TBL] [Abstract][Full Text] [Related]
23. [Progress of research on induced pluripotent stem cell models for Down syndrome].
Zhang T; Kong L; Sun G; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1183-1185. PubMed ID: 32924131
[TBL] [Abstract][Full Text] [Related]
24. Two cases of partial trisomy 21 (pter-q22.1) without the major features of Down syndrome.
Kondo Y; Mizuno S; Ohara K; Nakamura T; Yamada K; Yamamori S; Hayakawa C; Ishii T; Yamada Y; Wakamatsu N
Am J Med Genet A; 2006 Feb; 140(3):227-32. PubMed ID: 16411203
[TBL] [Abstract][Full Text] [Related]
25. Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse.
Dunlevy L; Bennett M; Slender A; Lana-Elola E; Tybulewicz VL; Fisher EM; Mohun T
Cardiovasc Res; 2010 Nov; 88(2):287-95. PubMed ID: 20558441
[TBL] [Abstract][Full Text] [Related]
26. A new mouse model for Down syndrome.
Kazuki Y; Schulz TC; Shinohara T; Kadota M; Nishigaki R; Inoue T; Kimura M; Kai Y; Abe S; Shirayoshi Y; Oshimura M
J Neural Transm Suppl; 2003; (67):1-20. PubMed ID: 15068235
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.
Pelleri MC; Gennari E; Locatelli C; Piovesan A; Caracausi M; Antonaros F; Rocca A; Donati CM; Conti L; Strippoli P; Seri M; Vitale L; Cocchi G
Genomics; 2017 Oct; 109(5-6):391-400. PubMed ID: 28648597
[TBL] [Abstract][Full Text] [Related]
28. The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.
Sailani MR; Makrythanasis P; Valsesia A; Santoni FA; Deutsch S; Popadin K; Borel C; Migliavacca E; Sharp AJ; Duriaux Sail G; Falconnet E; Rabionet K; Serra-Juhé C; Vicari S; Laux D; Grattau Y; Dembour G; Megarbane A; Touraine R; Stora S; Kitsiou S; Fryssira H; Chatzisevastou-Loukidou C; Kanavakis E; Merla G; Bonnet D; Pérez-Jurado LA; Estivill X; Delabar JM; Antonarakis SE
Genome Res; 2013 Sep; 23(9):1410-21. PubMed ID: 23783273
[TBL] [Abstract][Full Text] [Related]
29. Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.
El-Ruby M; Hemly NA; Zaki MS
Genet Couns; 2007; 18(2):217-26. PubMed ID: 17710874
[TBL] [Abstract][Full Text] [Related]
30. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
Olson LE; Richtsmeier JT; Leszl J; Reeves RH
Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
[TBL] [Abstract][Full Text] [Related]
31. A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome.
Pereira PL; Magnol L; Sahún I; Brault V; Duchon A; Prandini P; Gruart A; Bizot JC; Chadefaux-Vekemans B; Deutsch S; Trovero F; Delgado-García JM; Antonarakis SE; Dierssen M; Herault Y
Hum Mol Genet; 2009 Dec; 18(24):4756-69. PubMed ID: 19783846
[TBL] [Abstract][Full Text] [Related]
32. Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.
Cossec JC; Lavaur J; Berman DE; Rivals I; Hoischen A; Stora S; Ripoll C; Mircher C; Grattau Y; Olivomarin JC; de Chaumont F; Lecourtois M; Antonarakis SE; Veltman JA; Delabar JM; Duyckaerts C; Di Paolo G; Potier MC
Hum Mol Genet; 2012 Jul; 21(14):3156-72. PubMed ID: 22511594
[TBL] [Abstract][Full Text] [Related]
33. The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.
Duchon A; Pothion S; Brault V; Sharp AJ; Tybulewicz VL; Fisher EM; Herault Y
Behav Brain Res; 2011 Mar; 217(2):271-81. PubMed ID: 21047530
[TBL] [Abstract][Full Text] [Related]
34. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
[TBL] [Abstract][Full Text] [Related]
35. A
Weisfeld-Adams JD; Tkachuk AK; Maclean KN; Meeks NL; Scott SA
NPJ Genom Med; 2016; 1():16003-. PubMed ID: 27840696
[TBL] [Abstract][Full Text] [Related]
36. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.
Alford KA; Slender A; Vanes L; Li Z; Fisher EM; Nizetic D; Orkin SH; Roberts I; Tybulewicz VL
Blood; 2010 Apr; 115(14):2928-37. PubMed ID: 20154221
[TBL] [Abstract][Full Text] [Related]
37. Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6.
Yamamoto T; Shimojima K; Nishizawa T; Matsuo M; Ito M; Imai K
Am J Med Genet A; 2011 Jan; 155A(1):113-9. PubMed ID: 21204217
[TBL] [Abstract][Full Text] [Related]
38. Murine models for Down syndrome.
Dierssen M; Fillat C; Crnic L; Arbonés M; Flórez J; Estivill X
Physiol Behav; 2001 Aug; 73(5):859-71. PubMed ID: 11566219
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for Down syndrome.
Fillat C; Altafaj X
Prog Brain Res; 2012; 197():237-47. PubMed ID: 22541296
[TBL] [Abstract][Full Text] [Related]
40. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
